rFVIIa in ICH in Patients Treated With Anticoagulants or Anti-Platelets

NCT00222625 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Intracerebral Hemorrhage

Interventions

DRUG: rFVIIa + (vit K in AO patients)
DRUG: FFP or aPCC+ vit K in AO treated patients

Sponsor

University Of Perugia